24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Dov Greebaum
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
12:50
“Younger people are getting cancer more and more…we have to make kinder medicines.”
11:42
Armis sale to ServiceNow could yield $4 billion windfall for Insight Partners
10:40
Once valued at $600 million, what went wrong at collapsing Believer Meats
09:39
Shipping giant MSC submits bid for ZIM, challenging Hapag-Lloyd in takeover race
More stories
Buzz
Most popular
Daily
Weekly
1
Oracle’s stock has fallen 40% since Safra Catz announced her exit. Its latest earnings didn’t calm investors.
2
Freed Nvidia engineer Avinatan Or meets Jensen Huang at U.S. headquarters
3
After over $390 million in funding, Believer Meats abruptly shuts down
4
Jensen Huang’s quiet role emerges as Argamani describes Nvidia’s two-year vigil for Avinatan Or
5
ServiceNow in advanced talks to acquire Armis at around $7 billion valuation
More news
Dov Greebaum
2 stories about Dov Greebaum
Are smart contracts actual contracts?
21.11.21
|
Dov Greenbaum
“Maybe, smart contracts can promote a new theory of contracts that would encompass not only smart contracts, but other contracts as well,” writes Dov Greenbaum
Real World Data key to drug discovery, reducing carbon footprint of clinical trials
07.11.21
|
Dov Greenbaum
"If employed effectively, the use of RWD in clinical studies has the potential to be potent in many aspects of the drug discovery and regulatory pipeline," writes Dov Greenbaum